During the past decade, Wake Endoscopy Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wake Endoscopy Center" are "Gastroesophageal Reflux Disease (GERD)" (1 trials) and "Primary Biliary Cholangitis" (1 trials). Many other conditions were trialed in "Wake Endoscopy Center" in a lesser frequency.

Most popular intervention types in "Wake Endoscopy Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bezafibrate 100 MG" (1 trials), "Bezafibrate 200 MG" (1 trials), "Bezafibrate Placebo" (1 trials), "IW-3718" (1 trials) and "Obeticholic Acid 5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wake Endoscopy Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wake Endoscopy Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Wake Endoscopy Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wake Endoscopy Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".